Subscribe

U.S. Stem Cell, Inc. (USRM)

USD0.00 +0.00 (+0.00%)
US OTC Healthcare Biotechnology
Address 1560 Sawgrass Corporate Parkway 33323
Sunrise, FL, US
CEO Michael Tomas
IPO 2008-02-19
CIK 1388319 ISIN US90350U1007

Explore sections of this company profile

Description

U.S. Stem Cell, Inc. is a biotechnology firm dedicated to the advancement and commercialization of autologous cellular therapies throughout the United States. Its core mission is to address a range of medical conditions, including both chronic and acute forms of heart damage, along with various vascular and autoimmune disorders. Among its leading experimental treatments are MyoCell, a clinical-stage therapy designed to utilize a patient's own muscle cells to regenerate scar tissue within the heart, aiming to enhance cardiac function for individuals suffering from chronic heart failure. Another significant offering is AdipoCell, a cell therapy also derived from the patient's own body, developed to combat conditions such as acute myocardial infarction, persistent heart ischemia, and ischemia affecting the lower limbs. The company's developmental pipeline also features MyoCell SDF-1, another autologous cellular therapy derived from muscle, intended to boost cardiac performance in chronic heart failure patients. Furthermore, U.S. Stem Cell is actively developing MyoCath, an innovative deflecting-tip needle injection catheter specifically engineered to deliver therapeutic cells directly into heart tissue, addressing chronic heart ischemia and congestive heart failure. Beyond its product development, the company offers a suite of services, including training programs in regenerative medicine and cell therapy for both medical professionals and patients. It also facilitates cell collection and storage, provides specialized kits for cell collection and treatment for both human and veterinary applications, and manages its own cell therapy clinic. This clinic delivers cellular treatments for a broad spectrum of conditions, such as neurological, autoimmune, orthopedic, and degenerative disorders. Previously known as Bioheart, Inc., the company adopted its current name, U.S. Stem Cell, Inc., in October 2015. Established in 1999, its corporate headquarters are situated in Sunrise, Florida.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
USD0.00 +0.00 (+0.00%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
17.3K
Beta
-48.37
Float Shares
563.65M
Free Float %
87.9%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
+0.00% +0.00% +0.00% +0.00% +0.00% +9,900.00% +0.00% -96.15% -99.64% -99.73% -100.00%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Price Targets & DCF
Current price
0.00
Ratings Trend (MoM)
Rating 2024-11 Change
Strong Buy 0 0
Buy 0 0
Hold 0 0
Sell 0 0
Strong Sell 0 0
Quality scores
Altman Z-Score
-3,283.49
Distress
Piotroski F-Score
4 / 9
Average
MOAT Score
2 / 10
No MOAT
Operational MOAT
✗ Below peers
  • Revenue growth Biotechnology: +1.6%
    -59.1% Q4'22: -15.3% (vs Q4'21)
  • EPS growth Biotechnology: +29.7%
    +32.4% Q4'22: +35.7% (vs Q4'21)
  • FCF margin FCF growth · Biotechnology: +16.2%
    -3,135.5% Q4'22: -215.6% (vs Q4'21)
  • EBIT margin Biotechnology: +0.0%
    -2,642.3% Q4'22: -1,877.0% (vs Q4'21)
  • ROIC Biotechnology: -16.1%
    Q4'22: +25.8% (vs Q4'21)
  • Share dilution Biotechnology: -3.4%
    +28.4% Q4'22: +17.5% (vs Q4'21)
  • Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×
    -4.13× Q4'22: -5.97× (vs Q4'21)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
WACC components (optional)
Ke (Cost of Equity) = Rf + β (-48.37) × ERP
WACC = 1% × Ke + 99% × Kd (7.7%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
Current price: 0.00
Enterprise Value: Equity Value: Terminal Value: TV as % of EV:

Base values reflect the latest available data for this company and market conditions.

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
-309.3K
OE per share TTM
0.00
Owner's Yield
-522.90%
Maintenance CapEx ratio
Maint CapEx / Avg PPE
3.8%

Ownership Overview

Ownership breakdown

Ownership breakdown not available.

At a glance
Institutional holders
Total invested
Insider transactions (90d)
0
Beneficial owners (>5%)
9
Beneficial owners (>5%)
# Reporting person Amount owned % of class Sole voting Shared voting Sole dispositive Shared dispositive Type Citizenship Filing date SEC filing
1 Northstar Biotech Group, LLC 53.73M 7.95% 53.73M 53.73M CO Florida 2015-04-08
2 46-2977079 6.87M 9.99% 6.87M 6.87M CO Nevada 2016-12-06
3 J. Leonhardt 4.73M 32.70% 4.73M 4.73M IN States of America 2008-03-03
4 L. Leonhardt 4.73M 32.70% 4.73M 4.73M IN States of America 2008-03-03
5 45-2808501 2.92M 9.97% 2.92M 2.92M OO Nevada 2016-09-29
6 EIN: 45-2808501 438.8K 8.70% 438.8K 438.8K OO Nevada 2016-05-26
7 James S. Cassel 325.0K 7.80% 325.0K 325.0K IN United States of America 2016-04-28
8 Scott E. Salpeter 325.0K 7.80% 325.0K 325.0K IN United States of America 2016-04-28
9 TELLURIDE TOO, L.L.C. 325.0K 7.80% 325.0K 325.0K OO Florida 2016-04-28

Institutional Activity (13F)

Institutional ownership trend

Institutional history not available.

Top institutional holders

Top holders not available.

ETF Ownership

Top ETFs holding this stock

This company is not held by any ETF in our universe.

Insider Activity

Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
1
Sells
0
Shares acquired
2.50M
Shares disposed
Cash buys
Cash sales
Net activity
+2,500,000
Insider buys vs sells (history) From To
Recent insider transactions From To
Date Person Role Transaction A/D Security Shares Price Value Owned after D/I Filing
2022-04-25 Knutson Gregory Director A-Award A Common Stock 2,500,000 0.00 10.0K 29,175,000
2022-03-18 Knutson Gregory Director A-Award A Common Stock 25,000,000 0.01 200.0K 26,675,000
2022-02-24 Knutson Gregory Director A-Award A Warrant 12,500,000 0.01 100.0K 28,625,000
2021-04-02 Knutson Gregory Director J-Other A Common Stock 187,575 0.05 9.1K 35,474,544
2021-03-23 MURPHY WILLIAM P JR Director A-Award A Common Stock 7,518,797 0.03 200.0K 9,352,603
2021-02-17 Knutson Gregory Director A-Award A Convertible promissory Note (right to buy) 3,759,398 0.03 100.0K 7,384,398
2020-10-05 Knutson Gregory Director J-Other A Common Stock 2,035,820 0.00 9.2K 35,286,969
2020-04-01 Knutson Gregory Director J-Other A Common Stock 1,445,647 0.01 8.7K 32,251,149
2019-11-18 TOMAS MIKE Director / Officer A-Award A Stock Option (right to buy) 1,500,000 0.00 7.4K 81,541,284
2019-11-18 MURPHY WILLIAM P JR Director A-Award A Stock Option (right to buy) 1,500,000 0.00 7.4K 6,003,087
2019-11-18 Knutson Gregory Director A-Award A Stock Option (right to buy) 1,500,000 0.00 7.4K 3,625,000
2019-11-18 Borman Mark P Director A-Award A Stock Option (right to buy) 1,500,000 0.00 7.4K 6,002,810
2019-11-18 Anderson Sheldon T. Director A-Award A Stock Option (right to buy) 1,500,000 0.00 7.4K 6,001,400
2019-09-01 TOMAS MIKE Director / Officer A-Award A Stock Option (right to buy) 20,000,000 0.01 114.0K 80,041,284
2018-12-03 TOMAS MIKE Director / Officer A-Award A Stock Option (right to buy) 1,500,000 0.03 37.7K 60,041,284
2018-12-03 MURPHY WILLIAM P JR Director A-Award A Stock Option (right to buy) 1,500,000 0.03 37.7K 4,503,087
2018-12-03 Knutson Gregory Director A-Award A Stock Option (right to buy) 1,500,000 0.03 37.7K 2,125,000
2018-12-03 Comella Kristin C Director / Officer A-Award A Stock Option (right to buy) 1,500,000 0.03 37.7K 32,097,746
2018-12-03 Borman Mark P Director A-Award A Stock Option (right to buy) 1,500,000 0.03 37.7K 4,502,810
2018-12-03 Anderson Sheldon T. Director A-Award A Stock Option (right to buy) 1,500,000 0.03 37.7K 4,501,400
2018-10-19 Borman Mark P Director J-Other A Common Stock 526,918 0.03 14.2K 526,942
2018-05-07 TOMAS MIKE Director / Officer A-Award A Stock Option (right to buy) 20,000,000 0.05 1.07M 58,541,284
2018-05-07 Comella Kristin C Director / Officer A-Award A Stock Option (right to buy) 10,000,000 0.05 536.0K 30,697,746
2017-08-17 MURPHY WILLIAM P JR Director P-Purchase A Common Stock 1,799,614 0.03 49.8K 2,088,818
2017-08-07 TOMAS MIKE Director / Officer A-Award A Stock Option (right to buy) 15,000,000 0.03 489.0K 36,841,284
2017-08-07 MURPHY WILLIAM P JR Director A-Award A Stock Option (right to buy) 1,500,000 0.03 48.9K 3,003,087
2017-08-07 Knutson Gregory Director D Stock Option (right to buy) 625,000 0.03 20.4K 0
2017-08-07 Comella Kristin C Director / Officer A-Award A Stock Option (right to buy) 7,500,000 0.03 244.5K 19,197,746
2017-08-07 Borman Mark P Director A-Award A Stock Option (right to buy) 1,500,000 0.03 48.9K 3,002,810
2017-08-07 Anderson Sheldon T. Director A-Award A Stock Option (right to buy) 1,500,000 0.03 48.9K 3,001,400
2017-03-29 MURPHY WILLIAM P JR Director M-Exempt A Common Stock 1,748,947 0.03 58.6K 3,023,782
2017-03-06 MURPHY WILLIAM P JR Director P-Purchase A Common Stock 1,200,000 0.02 24.0K 1,274,835
2017-02-06 TOMAS MIKE Director / Officer A-Award A Stock Option (right to buy) 10,000,000 0.00 43.0K 21,841,284
2017-02-06 Comella Kristin C Director / Officer A-Award A Stock Options (right to buy) 5,000,000 0.00 21.5K 11,697,748
2016-09-19 TOMAS MIKE Director / Officer A-Award A Stock Option (right to buy) 1,500,000 0.02 29.4K 11,841,284
2016-09-19 MURPHY WILLIAM P JR Director A-Award A Stock Option (right to buy) 1,500,000 0.02 29.4K 1,503,087
2016-09-19 Comella Kristin C Director / Officer A-Award A Stock Options (right to buy) 1,500,000 0.02 29.4K 6,697,748
2016-09-19 Borman Mark P Director A-Award A Stock Option (right to buy) 1,500,000 0.02 29.4K 1,502,810
2016-09-19 Anderson Sheldon T. Director A-Award A Stock Option (right to buy) 1,500,000 0.02 29.4K 1,501,400
2016-02-11 MURPHY WILLIAM P JR Director C-Conversion A Common Stock 14,606 1.46 21.3K 74,833
2015-12-31 MURPHY WILLIAM P JR Director / 10% Owner C-Conversion A Common Stock 300 0.90 269.82 64,670
2015-12-30 MURPHY WILLIAM P JR Director / 10% Owner C-Conversion A Common Stock 1,850 0.90 1.7K 64,370
2015-12-29 MURPHY WILLIAM P JR Director / 10% Owner C-Conversion A Common Stock 900 0.90 809.64 62,520
2015-12-28 MURPHY WILLIAM P JR Director / 10% Owner C-Conversion A Common Stock 2,150 0.80 1.7K 61,620
2015-12-24 MURPHY WILLIAM P JR Director / 10% Owner C-Conversion A Common Stock 600 0.95 569.70 59,470
2015-12-23 MURPHY WILLIAM P JR Director / 10% Owner C-Conversion A Common Stock 1,150 0.79 907.93 58,870
2015-12-22 MURPHY WILLIAM P JR Director / 10% Owner C-Conversion A Common Stock 5,775 0.73 4.2K 57,720
2015-12-18 MURPHY WILLIAM P JR Director / 10% Owner C-Conversion A Common Stock 1,300 0.98 1.3K 51,945
2015-12-17 MURPHY WILLIAM P JR Director / 10% Owner C-Conversion A Common Stock 950 0.80 760.00 50,645
2015-12-16 MURPHY WILLIAM P JR Director / 10% Owner C-Conversion A Common Stock 4,250 1.00 4.2K 49,695
2015-12-15 MURPHY WILLIAM P JR Director / 10% Owner C-Conversion A Common Stock 400 1.11 444.00 45,445
2015-12-14 MURPHY WILLIAM P JR Director / 10% Owner C-Conversion A Common Stock 1,250 0.70 875.00 45,045
2015-12-11 TOMAS MIKE Director / Officer C-Conversion A Common Stock 1,514 0.68 1.0K 9,193
2015-12-11 MURPHY WILLIAM P JR Director / 10% Owner C-Conversion A Common Stock 146 0.75 109.41 43,795
2015-12-03 TOMAS MIKE Director / Officer C-Conversion A Common Stock 600 1.98 1.2K 8,279
2015-12-02 TOMAS MIKE Director / Officer C-Conversion A Common Stock 1,100 1.55 1.7K 7,679
2015-11-12 MURPHY WILLIAM P JR Director / 10% Owner P-Purchase A Common Stock 825 1.25 1.0K 43,430
2015-11-10 MURPHY WILLIAM P JR Director / 10% Owner P-Purchase A Common Stock 1,000 1.40 1.4K 42,605
2015-11-09 MURPHY WILLIAM P JR Director / 10% Owner P-Purchase A Common Stock 1,115 3.75 4.2K 41,605
2015-11-06 MURPHY WILLIAM P JR Director / 10% Owner P-Purchase A Common Stock 90 5.24 471.60 40,490
2015-11-06 AHN SAMUEL S Director P-Purchase A Common Stock 411 3.71 1.5K 42,806
2015-11-05 MURPHY WILLIAM P JR Director / 10% Owner P-Purchase A Common Stock 245 3.65 894.25 40,395
2015-11-05 AHN SAMUEL S Director P-Purchase A Common Stock 2,425 3.20 7.8K 42,395
2015-11-04 MURPHY WILLIAM P JR Director / 10% Owner C-Conversion A Common Stock 55 1.69 92.95 5,226
2015-11-04 AHN SAMUEL S Director P-Purchase A Common Stock 295 4.65 1.4K 39,970
2015-11-03 MURPHY WILLIAM P JR Director / 10% Owner P-Purchase A Common Stock 8,740 0.00 13.11 39,924
2015-11-03 AHN SAMUEL S Director P-Purchase A Common Stock 2,940 0.00 4.12 39,675
2015-11-02 TOMAS MIKE Director / Officer A-Award A Stock Option (right to buy) 10,000 6.24 62.4K 50,399
2015-11-02 Comella Kristin C Director / Officer A-Award A Stock Options (right to buy) 175,131 1.71 299.5K 192,762
2015-10-29 MURPHY WILLIAM P JR Director / 10% Owner P-Purchase A Common Stock 310,000 0.00 341.00 31,183,903
2015-10-28 MURPHY WILLIAM P JR Director / 10% Owner P-Purchase A Common Stock 3,019,998 0.00 3.6K 30,873,903
2015-10-27 MURPHY WILLIAM P JR Director / 10% Owner P-Purchase A Common Stock 400,000 0.00 480.00 27,853,905
2015-10-19 AHN SAMUEL S Director P-Purchase A Common Stock 2,999,997 0.00 3.3K 36,734,394
2015-10-16 MURPHY WILLIAM P JR Director / 10% Owner P-Purchase A Common Stock 1,099,999 0.00 1.4K 28,553,904
2015-10-15 MURPHY WILLIAM P JR Director / 10% Owner P-Purchase A Common Stock 999,999 0.00 1.6K 27,453,905
2015-10-09 MURPHY WILLIAM P JR Director / 10% Owner P-Purchase A Common Stock 700,000 0.00 910.00 26,453,906
2015-10-09 AHN SAMUEL S Director P-Purchase A Common Stock 2,499,998 0.00 3.2K 33,734,397
2015-10-06 MURPHY WILLIAM P JR Director / 10% Owner P-Purchase A Common Stock 199,500 0.00 279.30 25,753,906
2015-10-05 MURPHY WILLIAM P JR Director / 10% Owner P-Purchase A Common Stock 188,000 0.00 338.40 25,554,406
2015-10-02 MURPHY WILLIAM P JR Director / 10% Owner P-Purchase A Common Stock 1,999,998 0.00 3.6K 25,366,404
2015-10-01 MURPHY WILLIAM P JR Director / 10% Owner P-Purchase A Common Stock 2,499,998 0.00 4.2K 23,366,406
2015-09-30 MURPHY WILLIAM P JR Director / 10% Owner P-Purchase A Common Stock 750,000 0.00 1.4K 20,866,408
2015-09-29 MURPHY WILLIAM P JR Director / 10% Owner P-Purchase A Common Stock 4,099,996 0.00 7.8K 20,116,408
2015-05-22 AHN SAMUEL S Director P-Purchase A Common Stock 2,994,012 0.01 20.1K 31,234,399
2015-05-18 MURPHY WILLIAM P JR Director / 10% Owner P-Purchase A Common Stock 2,873,564 0.01 20.1K 16,016,412
2015-02-02 TOMAS MIKE Director / Officer A-Award A Stock Option (right to buy) 1,000,000 0.01 11.2K 40,398,487
2015-02-02 MURPHY WILLIAM P JR Director / 10% Owner A-Award A Stock Option (right to buy) 1,000,000 0.01 11.2K 3,723,529
2015-02-02 Hart Charles A Director A-Award A Stock Option (right to buy) 1,000,000 0.01 11.2K 8,871,430
2015-02-02 Comella Kristin C Director / Officer A-Award A Stock Option (right to buy) 1,000,000 0.01 11.2K 17,626,286
2015-02-02 Borman Mark P Director A-Award A Stock Option (right to buy) 1,000,000 0.01 11.2K 2,810,000
2015-02-02 Anderson Sheldon T. Director A-Award A Stock Option (right to buy) 1,000,000 0.01 11.2K 4,140,994
2015-02-02 AHN SAMUEL S Director A-Award A Stock Option (right to buy) 1,000,000 0.01 11.2K 12,657,750
2014-11-03 TOMAS MIKE Director / Officer A-Award A Stock Option (right to buy) 400,000 0.03 10.1K 39,398,487
2014-11-03 MURPHY WILLIAM P JR Director / 10% Owner A-Award A Stock Option (right to buy) 400,000 0.03 10.0K 2,723,529
2014-11-03 Hart Charles A Director A-Award A Stock Option (right to buy) 400,000 0.03 10.1K 7,871,430
2014-11-03 Comella Kristin C Director / Officer A-Award A Stock Option (right to buy) 400,000 0.03 10.1K 16,626,286
2014-11-03 Borman Mark P Director A-Award A Stock Option (right to buy) 400,000 0.03 10.0K 1,810,000
2014-11-03 Anderson Sheldon T. Director A-Award A Stock Option (right to buy) 400,000 0.03 10.0K 3,140,994
2014-11-03 AHN SAMUEL S Director A-Award A Stock Option (right to buy) 400,000 0.03 10.0K 11,657,750
2014-08-01 TOMAS MIKE Director / Officer A-Award A Stock option (right to buy) 10,000,000 0.03 269.0K 38,998,487
2014-08-01 Comella Kristin C Officer A-Award A Stock option (right to buy) 5,000,000 0.03 134.5K 16,262,286
2014-07-25 Hart Charles A Director J-Other A Common Stock 44,328 0.04 1.8K 9,194,422
2014-06-20 AHN SAMUEL S Director / 10% Owner J-Other A Common Stock - Conversion debt to equity 5,378,296 0.04 215.1K 28,240,387
2014-06-19 MURPHY WILLIAM P JR Director / 10% Owner J-Other A Common Stock - Conversion debt to equity 5,170,919 0.04 206.8K 13,942,848
2014-05-12 TOMAS MIKE Director / Officer A-Award A Stock option (right to buy) 4,298,487 0.03 116.9K 28,998,487
2014-02-24 TOMAS MIKE Director / Officer A-Award A Stock option (right to buy) 10,000,000 0.02 190.0K 24,700,000
2014-02-24 MURPHY WILLIAM P JR Director / 10% Owner A-Award A Stock option (right to buy) 800,000 0.02 15.2K 2,363,529
2014-02-24 Hart Charles A Director A-Award A Stock option (right to buy) 800,000 0.02 15.2K 7,312,440
2014-02-24 Comella Kristin C Officer A-Award A Stock option (right to buy) 5,000,000 0.02 95.0K 10,962,288
2014-02-24 Borman Mark P Director A-Award A Stock option (right to buy) 800,000 0.02 15.2K 1,410,000
2014-02-24 Anderson Sheldon T. Director A-Award A Stock option (right to buy) 800,000 0.02 15.2K 2,740,994
2014-02-24 AHN SAMUEL S Director / 10% Owner A-Award A Stock option (right to buy) 800,000 0.02 15.2K 19,019,716
2013-09-30 TOMAS MIKE Director / Officer J-Other A Common Stock Conversion of debt to equity 6,578,947 0.01 92.1K 6,578,947
2013-09-30 MURPHY WILLIAM P JR Director / 10% Owner J-Other A Common Stock Conversion of debt to equity 8,771,929 0.01 122.8K 8,771,929
2013-09-30 Hart Charles A Director J-Other A Common Stock Conversion of debt to equity 1,995,614 0.01 27.9K 9,150,094
2013-09-30 AHN SAMUEL S Director / 10% Owner P-Purchase A Common Stock Conversion of debt to equity. 8,771,929 0.01 122.8K 22,862,091
2013-09-01 TOMAS MIKE Director / Officer A-Award A Stock option (right to buy) 400,000 0.02 8.0K 13,900,000
2013-09-01 MURPHY WILLIAM P JR Director / 10% Owner A-Award A Stock option (right to buy) 400,000 0.02 8.0K 2,563,529
2013-09-01 Hart Charles A Director A-Award A Stock option (right to buy) 400,000 0.02 8.0K 6,512,440
2013-09-01 Borman Mark P Director A-Award A Stock option (right to buy) 400,000 0.02 8.0K 610,000
2013-09-01 AHN SAMUEL S Director / 10% Owner A-Award A Stock option (right to buy) 400,000 0.02 8.0K 11,019,716
2013-08-28 Anderson Sheldon T. Director D Common Stock 0 0.00 1,940,994
2013-08-26 Anderson Sheldon T. Director D Warrant (right to buy) 1,940,994 0.03 50.1K 0
2013-08-01 TOMAS MIKE Director / Officer A-Award A Stock option (right to buy) 10,000,000 0.02 200.0K 13,500,000
2013-08-01 Comella Kristin C Officer A-Award A Stock option (right to buy) 5,000,000 0.02 100.0K 5,562,288
2012-08-06 TOMAS MIKE Director / Officer A-Award A Stock option (right to buy) 2,000,000 0.02 40.0K 3,500,000
2012-08-06 Comella Kristin C Officer A-Award A Stock option (right to buy) 500,000 0.02 10.0K 562,288
2012-07-10 AHN SAMUEL S Director / 10% Owner P-Purchase A Common Stock 2,500,000 0.03 75.0K 14,090,162
2012-05-16 AHN SAMUEL S Director / 10% Owner A-Award A Warrant (right to buy) 2,500,000 0.02 50.0K 10,619,716
2012-02-06 Hart Charles A Director P-Purchase A Common Stock 3,571,430 0.01 50.0K 7,154,480
2012-01-30 AHN SAMUEL S Director / 10% Owner P-Purchase A Common Stock 5,500,000 0.02 110.0K 11,590,162
2012-01-16 TOMAS MIKE Director / Officer A-Award A Stock Option (right to buy) 500,000 0.10 50.0K 1,500,000
2011-12-31 Hart Charles A Director I Common Stock 0 0.00 423,870
2011-12-15 Hart Charles A Director A-Award A Warrant (right to buy) 2,200,000 0.03 66.0K 2,969,110
2011-12-01 AHN SAMUEL S Director P-Purchase A Common Stock 1,084,200 0.05 54.2K 6,090,162
2011-09-12 Comella Kristin C Officer A-Award A Stock Option (right to buy) 250,000 0.10 25.0K 362,286
2011-08-29 SPENCER RICHARD III Director A-Award A Stock Option (right to buy) 100,000 0.07 7.0K 289,135
2011-08-29 MURPHY WILLIAM P JR Director / 10% Owner A-Award A Stock Option (right to buy) 300,000 0.07 21.0K 433,534
2011-08-29 Leonhardt Howard J Director / Officer / 10% Owner A-Award A Stock Option (right to buy) 100,000 0.07 7.0K 126,379
2011-08-29 Hart Charles A Director A-Award A Stock Option (right to buy) 460,000 0.07 32.2K 570,000
2011-08-29 CARSON BRUCE C Director A-Award A Stock Option (right to buy) 100,000 0.07 7.0K 350,912
2011-08-29 Borman Mark P Director A-Award A Stock Option (right to buy) 150,000 0.07 10.5K 210,000
2011-08-29 AHN SAMUEL S Director A-Award A Stock Option (right to buy) 100,000 0.07 7.0K 219,134
2011-08-12 TOMAS MIKE Director / Officer A-Award A Stock Option (right to buy) 500,000 0.10 50.0K 1,000,000
2011-08-12 SULAWSKE-GUCK CATHERINE Officer P-Purchase A Stock Option (right to buy) 250,000 0.10 25.0K 360,000
2011-08-12 SPENCER RICHARD III Director A-Award A Stock Option (right to buy) 40,000 0.21 8.4K 189,135
2011-08-12 MURPHY WILLIAM P JR Director / 10% Owner A-Award A Stock Option (right to buy) 40,000 0.21 8.4K 133,534
2011-08-12 Hart Charles A Director A-Award A Stock Option (right to buy) 40,000 0.21 8.4K 110,000
2011-08-12 CARSON BRUCE C Director A-Award A Stock Option (right to buy) 40,000 0.21 8.4K 250,912
2011-08-12 Borman Mark P Director A-Award A Stock Option (right to buy) 40,000 0.21 8.4K 60,000
2011-08-12 AHN SAMUEL S Director A-Award A Stock Option (right to buy) 10,000 0.21 2.1K 119,134
2011-07-29 MURPHY WILLIAM P JR Director / 10% Owner A-Award A Warrant (right to buy) 1,666,670 0.06 100.0K 2,163,529
2011-04-06 AHN SAMUEL S Director P-Purchase A Common Stock 97,400 0.15 15.0K 2,502,512
2011-03-31 AHN SAMUEL S Director P-Purchase A Common Stock 163,400 0.15 25.0K 2,405,112
2011-03-29 AHN SAMUEL S Director P-Purchase A Common Stock 167,790 0.15 25.0K 2,241,712
2011-03-28 AHN SAMUEL S Director P-Purchase A Common Stock 246,480 0.14 35.0K 2,073,922
2010-12-31 TOMAS MIKE Director / Officer I Common Stock 0 0.00 44,738
2010-12-31 MURPHY WILLIAM P JR Director / 10% Owner I Common Stock 0 0.00 3,232,027
2010-12-31 Hart Charles A Director D Common Stock 0 0.00 1,383,050
2010-12-13 Hart Charles A Director P-Purchase A Common Stock 675,580 0.15 101.3K 1,897,901
2010-11-30 MURPHY WILLIAM P JR Director A-Award A Warrant (right to buy) 1,539,770 0.18 277.2K 3,183,547
2010-11-30 Hart Charles A Director A-Award A Warrant (right to buy) 90,310 0.18 16.3K 341,797
2010-09-18 TOMAS MIKE Director / Officer A-Award A Stock Option (right to buy) 500,000 0.50 250.0K 500,000
2010-06-01 MURPHY WILLIAM P JR Director / 10% Owner A-Award A Warrant (right to buy) 23,167 7.69 178.2K 69,503
2010-04-20 FARLEY PEGGY A Director / Officer P-Purchase A Common Stock 77,230 0.54 41.7K 1,597,747
2010-04-01 FARLEY PEGGY A Director / Officer P-Purchase A Common Stock 452,290 0.67 303.0K 1,520,517
2010-03-29 Leonhardt Howard J Director / Officer / 10% Owner A-Award A Warrant (right to buy) 940,956 0.79 743.4K 1,030,989
2010-03-16 Hart Charles A Director P-Purchase A Common Stock 7,200 0.54 3.9K 1,041,701
2010-03-05 Hart Charles A Director A-Award A Warrant (right to buy) 108,963 0.64 69.7K 786,390
2010-03-04 Hart Charles A Director P-Purchase A Common Stock 103,770 0.53 55.0K 1,138,271
2010-02-26 MURPHY WILLIAM P JR Director P-Purchase A Common Stock 45,000 0.58 26.1K 304,984
2010-02-26 FARLEY PEGGY A Director / Officer P-Purchase A Common Stock 8,000 0.58 4.6K 1,068,227
2010-02-26 Borman Mark P Director A-Award A Warrant (right to buy) 7,035 0.70 4.9K 7,035
2010-02-11 SULAWSKE-GUCK CATHERINE Officer A-Award A Stock Option (right to buy) 22,584 0.68 15.4K 110,000
2010-02-11 SPENCER RICHARD III Director A-Award A Stock Option (right to buy) 40,000 0.68 27.2K 149,135
2010-02-11 Lee A Jones Director A-Award A Stock Option (right to buy) 10,000 0.68 6.8K 10,000
2010-02-11 Hart Charles A Director A-Award A Stock Option (right to buy) 20,000 0.68 13.6K 319,327
2010-02-11 Groth Karl Director / Officer A-Award A Stock Option (right to buy) 40,000 0.68 27.2K 40,000
2010-02-11 FARLEY PEGGY A Director / Officer X-InTheMoney D Stock Option (right to buy) 307,692 0.00 307.69 35,000
2010-02-11 CARSON BRUCE C Director A-Award A Stock Option (right to buy) 40,000 0.68 27.2K 210,912
2010-02-11 Borman Mark P Director A-Award A Stock Option (Right to buy) 20,000 0.68 13.6K 20,000
2010-02-02 FARLEY PEGGY A Director / Officer A-Award A Stock Option (right to buy) 307,692 0.00 307.69 342,692
2009-11-14 Hart Charles A Director D Warrant (right to buy) 22,059 0.82 18.1K 0
2009-11-05 Lee A Jones Director 0 0.00 0
2009-11-05 Hart Charles A Director A-Award A Stock Option (right to buy) 50,000 0.83 41.5K 299,327
2009-10-16 Hart Charles A Director D Warrant (right to buy) 26,316 0.68 17.9K 0
2009-10-01 Hart Charles A Director D Warrant (right to buy) 183,672 0.59 108.4K 0
2009-07-01 MURPHY WILLIAM P JR Director P-Purchase A Common Stock 140,850 0.71 100.0K 214,984
2009-06-11 Leonhardt Howard J Director / Officer / 10% Owner P-Purchase A Common Stock 64,790 0.71 46.0K 5,027,681
2009-06-04 Leonhardt Howard J Director / Officer / 10% Owner A-Award A Warrant (right to buy) 12,972 0.89 11.5K 262,022
2009-05-29 Leonhardt Howard J Director / Officer / 10% Owner A-Award A Warrant (right to buy) 18,801 0.90 16.9K 249,050
2009-05-14 SULAWSKE-GUCK CATHERINE Officer A-Award A Stock Option (right to buy) 40,000 0.85 34.0K 87,416
2009-05-14 Leonhardt Howard J Director / Officer / 10% Owner A-Award A Warrant (right to buy) 38,823 0.82 31.8K 230,249
2009-05-14 Comella Kristin C Officer A-Award A Stock Option (right to buy) 30,000 0.85 25.5K 97,286
2009-05-12 Hart Charles A Director D Common Stock 0 0.00 1,034,501
2009-05-12 Borman Mark P Director 0 0.00 0
2009-04-01 Hart Charles A Director D Warrant (right to buy) 17,280 2.60 44.9K 0
2009-03-13 Fendrich Matthew J Officer A-Award A Stock Option (right to buy) 675 0.74 499.50 105,675
2009-03-13 Comella Kristin C Officer A-Award A Stock Option (right to buy) 2,955 0.74 2.2K 82,286
2009-01-19 Groth Karl Director I Common Stock 0 0.00 467,400

Executive team

Top executives
EBIT / Employee
-2.0K
Shares Outstanding
641.51M

Executive compensation

Executive compensation (annual)
# Year Executive Salary Bonus Stock award Option award Incentive Other Total % Stock-
based
Filing
1 2013 Mike Tomas CEO, President, CFO and Director 391.7K 375.0K 170.1K 936.8K 18.16%
2 2013 Kristin Comella Chief Science Officer and Director 159.2K 125.0K 81.9K 366.1K 22.38%
3 2012 Mike Tomas CEO, President, CFO and Director 247.6K 100.0K 347.6K 28.77%
4 2012 Kristin Comella Chief Science Officer and Director 105.7K 105.7K 0.00%
5 2007 William M. Pinon President & Chief Executive Officer 220.2K 226.8K 447.0K 50.74%
6 2007 William H. Kline Chief Financial Officer 130.0K 240.0K 370.0K 64.87%
7 2007 Richard T. Spencer, IV Vice President of Clinical Affairs and Physician Relations 129.6K 70.0K 199.6K 35.07%
8 2007 Howard J. Leonhardt Chairman of the Board and Chief Technology Officer 150.0K 150.0K 0.00%
9 2007 Scott Bromley Vice President of Public Relations 130.0K 130.0K 0.00%
10 2006 Scott Bromley Vice President of Public Relations 130.0K 1.0K 366.4K 2.93M 153.0K 3.58M 92.06%
11 2006 Richard T. Spencer, IV Vice President of Clinical Affairs and Physician Relations 125.0K 1.0K 62.8K 188.8K 33.26%
12 2006 Howard J. Leonhardt Chairman of the Board and Chief Technology Officer 150.0K 1.0K 151.0K 0.00%
13 2006 William H. Kline Chief Financial Officer 50.0K 1.0K 6.0K 147.0K 4.08%
CEO compensation breakdown

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings
Filing date Form type Filing
2023-05-15 NT 10-Q
2023-04-14 10-K
2023-03-31 NT 10-K
2022-11-09 10-Q
2022-08-22 10-Q
2022-08-15 NT 10-Q
2022-08-01 UPLOAD
2022-07-27 CORRESP
2022-07-08 10-K/A
2022-06-27 UPLOAD

Executive team

NameTitleCompensationGender
Evelyn Flores Corporate Controller female
Michael Tomas Chief Executive Officer, President, Chief Financial Officer & Director male
Sergio Pinski Medical Director & Member of Scientific Advisory Board
ESG Rating
B
BIOTECHNOLOGY
2022
E (Environmental)
61.5 / 56.3
Company / Sector avg.
S (Social)
71.0 / 62.4
Company / Sector avg.
G (Governance)
62.4 / 60.9
Company / Sector avg.
ESG Total
65.0 / 59.9
Company / Sector avg.
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend history

Earnings history

Earnings reports

Stock splits